Companies / India
Clinton Foundation Negotiates Price Cuts On Paediatric ARVs
December 2006 | Industry NewsThe Clinton Foundation has announced that two leading Indian generics firms - Cipla and Ranbaxy - will drastically cut prices for paediatric antiretrovirals (ARVs). The drugs, which slow the progression of the HIV virus, will be made available at prices as low as US$0.16 per day, or about US$60 per year. This is around 45% less than the current lowest prices available in developing
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
